| Xamoterol monotherapy in heart failure. The European 'Corwin' Group. | |
| | |
MedLine Citation:
|
PMID: 1971596 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The effect of xamoterol as sole therapy was investigated in randomized, double-blind, placebo-controlled studies involving 425 patients with mild to moderate heart failure. When compared with placebo, xamoterol produced improvements in exercise capacity, clinical signs, symptoms and quality of life with a low incidence of adverse experiences. Xamoterol is effective as monotherapy in heart failure. |
| | |
Authors:
|
R M Timewell; R D Stark; H F Marlow |
Related Documents
:
|
20883926 - Coenzyme q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified sub... 17075376 - Fast-track failure after cardiac surgery: development of a prediction model. 23548336 - Retrograde cardioplegia revisited: open technique for long aortic cross clamping. 12793706 - Heart failure in the elderly. 18040676 - Evaluation of postoperative pulmonary regurgitation after surgical repair of tetralogy ... 16563786 - The effect of ventricular sequential contraction on helical heart during pacing: high s... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: European heart journal Volume: 11 Suppl A ISSN: 0195-668X ISO Abbreviation: Eur. Heart J. Publication Date: 1990 Apr |
Date Detail:
|
Created Date: 1990-07-05 Completed Date: 1990-07-05 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8006263 Medline TA: Eur Heart J Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 62-4 Citation Subset: IM |
Affiliation:
|
ICI Pharmaceuticals, Macclesfield, Cheshire, U.K. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Agonists
/
adverse effects,
therapeutic use* Aged Cardiac Output, Low / drug therapy* Double-Blind Method Drug Evaluation Humans Propanolamines / adverse effects, therapeutic use* Randomized Controlled Trials as Topic Xamoterol |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Agonists; 0/Propanolamines; 81801-12-9/Xamoterol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of xamoterol on haemodynamics and plasma catecholamines in chronic heart failure.
Next Document: A patient-powered treadmill--a simple alternative means of assessing heart failure and treatment in ...